Search
-
We’ve led the way in developing an innovative approach to safely delivering high doses of radiation to parts of the body affected by mesothelioma.
… In addition to innovations we’ve made in safely delivering radiation therapy, Memorial Sloan Kettering often has radiation-related clinical trials open for enrollment to people with mesothelioma. The radiation approach we recommend for you depends on what type of mesothelioma you have. Radiation Therapy
-
The most common sign of bladder cancer is blood in the urine. Learn more about what to look for and other symptoms that may be present.
… Blood in the urine (hematuria) is the most common sign of bladder cancer. This is a warning sign of bladder cancer for all genders, and for non-muscle invasive (NMIBC) and invasive bladder cancer. Muscle invasive bladder cancer means the cancer is in the muscle of the bladder. Most bladder cancer is
-
Learn about Memorial Sloan Kettering’s approach to diagnosing bladder cancer.
… Before you start treatment, your doctor first will get a clear understanding of the cause of your symptoms. To make their diagnosis, MSK experts learn about your medical history and overall health. They will give you a thorough exam and diagnostic tests, such as: Cystoscopy and Transurethral Resection
-
MSK uses the latest technology to give you the most accurate prostate cancer diagnosis. Learn more.
… We understand that a diagnosis of prostate cancer can cause a lot of anxiety and uncertainty. Our experts will use the latest technology to give you the most accurate diagnosis possible. We want you to feel confident about your next step, whether it’s active surveillance for your disease or starting
-
MSK utiliza la última tecnología para brindarle el diagnóstico de cáncer de próstata más preciso. Averigüe más.
… Entendemos que un diagnóstico de cáncer de próstata puede provocar mucha ansiedad e incertidumbre. Nuestros expertos utilizarán la última tecnología para brindarle el diagnóstico más preciso posible. Queremos que se sienta seguro con respecto a cuál será su próximo paso, ya sea la observación activa
-
Learn about all of the different neuroblastoma treatment options and pioneering therapies available to you at Memorial Sloan Kettering Cancer Center.
… Once we know the stage of your child’s neuroblastoma, we’ll speak with you about the best treatments. At MSK Kids, your child has access to every type of neuroblastoma treatment, including surgery, chemotherapy, radiation therapy, immunotherapies with antibodies, cancer vaccines, T-cells and NK-cells
-
Brain Metastases
Brain metastases (secondary brain cancer) is when cancer spreads to the brain from another part of the body. Learn more about symptoms and treatment at MSK.
… What is Brain Metastases? Brain metastases, or metastatic brain cancer, is when cancer spreads to the brain from another part of the body. Also known as secondary brain cancer, it’s much more common than primary brain cancer , which starts in the brain. Because brain metastases is hard to treat, MSK
-
Neurofibromatosis and Schwannomatosis
Learn more about neurofibromatosis symptoms and diagnosis and discover how MSK is providing treatment for people with this genetic condition.
… What are neurofibromatosis and schwannomatosis? Neurofibromatosis (NOOR-oh-FY-broh-muh-TOH-sis) and schwannomatosis (shwah-NOH-muh-TOH-sis) are rare genetic conditions. They make it more likely you will get tumors. Many of these tumors are not cancer. But they can harm you. These tumors can make you
-
Explore how we use chemotherapy, including hepatic arterial infusion therapy, to treat primary liver cancer.
… Chemotherapy uses chemical substances to destroy cancer cells wherever they are in the body. Depending on your particular situation, we may recommend chemotherapy before surgery to help shrink your liver tumor. This is called adjuvant therapy . Chemotherapy can also help in lowering the risk that the
-
Acute myeloid leukemia (AML) is one of the most common leukemias in adults. Learn more about AML and how it’s diagnosed.
… Acute myeloid leukemia (AML), one of the most common leukemias in adults, is diagnosed in about 20,000 people in the United States each year. The average age at diagnosis is 72. The disease affects more men than women. New Patient Appointments Call 646-497-9154 We’re available 24 hours a day, 7 days